Rare immune disorder drug tested for long-term safety in just 2 patients
Disease control
Recruiting now
This study looks at the long-term safety of a drug called AVTX-803 in people with a very rare immune disorder called LAD II. Only 2 people who completed a previous study can join. The goal is to see if the drug is safe over time and if it helps control the disease.
Phase: PHASE3 • Sponsor: AUG Therapeutics • Aim: Disease control
Last updated May 09, 2026 04:50 UTC